SHW Stock Analysis: Sherwin-Williams | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 83.480m USD | 12M Return: 4.6% | US8243481061 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 670M
EPS Trend: 93.3%
Qual. Beats: 0
Rev. Trend: 80.1%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sherwin-Williams Co. (SHW) is a global manufacturer and distributor of paints, coatings, and related products serving professional, industrial, commercial, and retail customers. The company operates through three business segments - Paint Stores Group, Consumer Brands Group, and Performance Coatings Group - which collectively cover architectural coatings, industrial and protective finishes, automotive refinish products, wood finishes, and specialty resins sold via company-owned retail stores, home centers, dealers, and third-party distributors. Headquartered in Cleveland, Ohio, and founded in 1866, SHW has expanded its operations across North America, South America, the Caribbean, Europe, Asia, and Australia, and has been publicly traded on the NYSE since 1985.
The company is classified within the GICS Materials sector, under the Specialty Chemicals sub-industry, reflecting that coatings are formulated chemical products rather than basic commodities. A defining feature of Sherwin-Williams business model is its vertical integration: it develops and manufactures coatings in-house and sells them directly to end users through its proprietary Sherwin-Williams-branded stores, a structure that distinguishes it from competitors who rely more heavily on independent distribution channels.
- Housing starts and DIY demand boost Paint Stores Group sales
- Raw material costs squeeze margins despite pricing actions
- Performance Coatings cyclical exposure weighs on industrial volume growth
| Net Income: 2.69b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.43 > 1.0 |
| NWC/Revenue: -10.77% < 20% (prev -7.67%; Δ -3.09% < -1%) |
| CFO/TA 0.14 > 3% & CFO 3.89b > Net Income 2.69b |
| Net Debt (16.1b) to EBITDA (4.72b): 3.40 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (247.1m) vs 12m ago -1.91% < -2% |
| Gross Margin: 49.07% > 18% (prev 48.87%; Δ 0.20% > 0.5%) |
| Asset Turnover: 93.32% > 50% (prev 91.00%; Δ 2.32% > 0%) |
| Interest Coverage Ratio: 7.73 > 6 (EBIT TTM 3.99b / Interest Expense TTM 516.3m) |
| A: -0.10 (Total Current Assets 7.00b - Total Current Liabilities 9.63b) / Total Assets 27.0b |
| B: 0.07 (Retained Earnings 2.01b / Total Assets 27.0b) |
| C: 0.15 (EBIT TTM 3.99b / Avg Total Assets 26.2b) |
| D: 0.17 (Book Value of Equity 3.85b / Total Liabilities 23.1b) |
| Altman-Z'' = 0.81 = B |
| DSRI: 1.09 (Receivables 3.57b/3.11b, Revenue 24.4b/23.1b) |
| GMI: 1.00 (GM 48.87% / 49.07%) |
| AQI: 0.98 (AQ_t 0.51 / AQ_t-1 0.52) |
| SGI: 1.06 (Revenue 24.4b / 23.1b) |
| TATA: -0.04 (NI 2.69b - CFO 3.89b) / TA 27.0b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of August 07, 2026, the stock is trading at USD 363.42 with a total of 1,333,973 shares traded. Over the past week, the price has changed by +5.39%, over one month by +4.09%, over three months by +12.59% and over the past year by +4.59%.
Current recommended Stop Loss: 347.70 (which is 4.3% or 1.5 ATR below the current price).
Sherwin-Williams has received a consensus analysts rating of 3.79. Therefore, it is recommended to hold SHW.
- StrongBuy: 10
- Buy: 5
- Hold: 11
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 379.6 | 4.5% |
P/E Trailing = 33.0019
P/E Forward = 30.1205
P/S = 3.4199
P/B = 19.7187
P/EG = 2.7375
Revenue TTM = 24.4b USD
EBIT TTM = 3.99b USD
EBITDA TTM = 4.72b USD
Long Term Debt = 8.33b USD (from longTermDebt, last quarter)
Short Term Debt = 4.72b USD (from shortTermDebt, last quarter)
Debt = 16.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.14b
Net Debt = 16.1b USD (calculated: Debt 16.4b - CCE 293.5m)
Enterprise Value = 99.5b USD (83.5b + Debt 16.4b - CCE 293.5m)
Interest Coverage Ratio = 7.73 (Ebit TTM 3.99b / Interest Expense TTM 516.3m)
EV/FCF = 30.98x (Enterprise Value 99.5b / FCF TTM 3.21b)
FCF Yield = 3.23% (FCF TTM 3.21b / Enterprise Value 99.5b)
FCF Margin = 13.16% (FCF TTM 3.21b / Revenue TTM 24.4b)
Net Margin = 11.01% (Net Income TTM 2.69b / Revenue TTM 24.4b)
Gross Margin = 49.07% ((Revenue TTM 24.4b - Cost of Revenue TTM 12.4b) / Revenue TTM)
Gross Margin QoQ = 49.17% (prev 49.07%)
Tobins Q-Ratio = 3.69 (Enterprise Value 99.5b / Total Assets 27.0b)
Interest Expense / Debt = 3.16% (Interest Expense 516.3m / Debt 16.4b)
Taxrate = 23.01% (803.6m / 3.49b)
NOPAT = 3.07b (EBIT 3.99b * (1 - 23.01%))
Current Ratio = 0.73 (Total Current Assets 7.00b / Total Current Liabilities 9.63b)
Debt / Equity = 4.24 (Debt 16.4b / totalStockholderEquity, last quarter 3.85b)
Debt / EBITDA = 3.40 (Net Debt 16.1b / EBITDA 4.72b)
Debt / FCF = 5.00 (Net Debt 16.1b / FCF TTM 3.21b)
Total Stockholder Equity = 4.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.28% (Net Income 2.69b / Total Assets 27.0b)
RoE = 62.12% (Net Income TTM 2.69b / Total Stockholder Equity 4.33b)
RoCE = 31.56% (EBIT 3.99b / Capital Employed (Equity 4.33b + L.T.Debt 8.33b))
RoIC = 14.14% (NOPAT 3.07b / Invested Capital 21.7b)
WACC = 7.21% (E(83.5b)/V(99.8b) * Re(8.15%) + D(16.4b)/V(99.8b) * Rd(3.16%) * (1-Tc(0.23)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.60 | Cagr: -1.53%
[DCF] Terminal Value 77.97% ; FCFF base≈2.79b ; Y1≈3.20b ; Y5≈4.71b
[DCF] Fair Price = 225.6 (EV 70.8b - Net Debt 16.1b = Equity 54.8b / Shares 242.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.34 | EPS CAGR: 4.68% | SUE: 0.68 | # QB: 0
Revenue Correlation: 80.07 | Revenue CAGR: 1.72% | SUE: 2.16 | # QB: 2
EPS current Quarter (2026-09-30): EPS=3.60 | Chg30d=+0.68% | Revisions=+0% | Analysts=15
EPS current Year (2026-12-31): EPS=11.82 | Chg30d=+0.75% | Revisions=-30% | GrowthEPS=+3.4% | GrowthRev=+4.9%
EPS next Year (2027-12-31): EPS=13.32 | Chg30d=+0.52% | Revisions=+22% | GrowthEPS=+12.6% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: -5% (up=8, down=9)